SXT Earnings

SXT reported its earnings on 2026-02-13, showcasing a revenue of 393.45M against an estimate of 1.61B, resulting in a -75.56% surprise. The EPS was 0.72, surpassing the expected 0.78 by -7.69%. The stock experienced a -5% price change on the earnings day and a -7.39% change over the next five days, reflecting market reactions to the results.

Following SXT's earnings announcement on 2026-02-13, the stock price moved by -5% on the day of the release. Over the subsequent five days, it saw a -7.39% change. Historically, SXT's stock price tends to shift by an average of -1.95% in the 10 days leading up to earnings and 2.1% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate SXT's annual revenue to reach 416.10M, while the EPS is projected at 0.97. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between SXT's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, SXT's stock price typically moves by -1.95% in the 10 days before its earnings and 2.1% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 0.97 and revenue of 416.10M.

The company shows strong financial performance with improved cash flow and adjusted operating income, driven by strategic investments in natural color conversion and flavor technologies. Despite some uncertainties in conversion timelines and margin impacts, the guidance for double-digit growth in key areas like the Color Group and Flavors & Extracts suggests optimism. The strategic focus on regulatory-driven opportunities and investment in R&D further supports a positive outlook. Given the market cap, the stock is likely to react positively, but not excessively, resulting in a 2% to 8% increase.